Back
Summit Therapeutics Stock Price Chart
Sponsored
SMMT
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
51
SMMT
Summit Therapeutics
Last Price:
19.97
Seasonality Move:
36.48%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- The current trend is relatively stagnant and SMMT is experiencing slight buying pressure.
Summit Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.12 | Sell |
20-day SMA: | 20.25 | Sell |
50-day SMA: | 19.93 | Buy |
200-day SMA: | 9.62 | Buy |
8-day EMA: | 19.9 | Buy |
20-day EMA: | 20.24 | Sell |
50-day EMA: | 18.93 | Buy |
200-day EMA: | 11.62 | Buy |
Summit Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 49.15 | Sell |
Chaikin Money Flow: | 605639 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.86 - 21.48) | Sell |
Bollinger Bands (100): | (8.54 - 20.92) | Buy |
Summit Therapeutics Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 19.96 while SMMT 8-day simple moving average is 20.12, which is a Sell signal.
- The stock price of SMMT is 19.96 while Summit Therapeutics 20-day SMA is 20.25, which makes it a Sell.
- Summit Therapeutics 50-day simple moving average is 19.93 while SMMT share price is 19.96, making it a Buy technically.
- SMMT stock price is 19.96 and Summit Therapeutics 200-day simple moving average is 9.62, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
51
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a Buy
The current Summit Therapeutics [SMMT] share price is $19.96. The Score for SMMT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
14.72B
Price in USD:
19.96
Share Volume:
1.9M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
1.64
Buy
51
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?
The Summit Therapeutics stock price is 19.96 USD today. -
Will SMMT stock go up or go down?
Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Summit Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 19.96 while SMMT 8-day exponential moving average is 19.90, which is a Buy signal.
- The stock price of SMMT is 19.96 while Summit Therapeutics 20-day EMA is 20.24, which makes it a Sell.
- Summit Therapeutics 50-day exponential moving average is 18.93 while SMMT share price is 19.96, making it a Buy technically.
- SMMT stock price is 19.96 and Summit Therapeutics 200-day simple moving average is 11.62, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
- SMMT Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Summit Therapeutics is a Sell
- Summit Therapeutics Relative Strength Index (RSI) is 49.15, which suggest Summit Therapeutics is oversold
- The Bollinger Bands (25) for Summit Therapeutics is (18.86 - 21.48), which suggest Summit Therapeutics is a Buy
- The Bollinger Bands (100) for Summit Therapeutics is (8.54 - 20.92), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.